139 related articles for article (PubMed ID: 7912856)
1. Multi-locus analysis of HLA class II genes in DR2-positive IDDM haplotypes in Finland. The "Childhood Diabetes in Finland" (DiMe) Study Group.
Reijonen H; Ilonen J; Akerblom HK; Knip M; Dosch HM
Tissue Antigens; 1994 Jan; 43(1):1-6. PubMed ID: 7912856
[TBL] [Abstract][Full Text] [Related]
2. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR2 haplotypic diversity in populations of South-East Asia, northern China, Melanesia and Australian aborigines using PCR-RFLP for DRB1, DRB5, DQA1 and DQB1. A novel DRB1 allele: DRB1*16022.
Trejaut J; Bhatia K; Greville WD; Hu KR; Duraisamy G; Nuchprayoon C; Donald J; Aziz A; Dunckley H
Eur J Immunogenet; 1996 Dec; 23(6):437-49. PubMed ID: 8971541
[TBL] [Abstract][Full Text] [Related]
4. Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes.
Erlich HA; Griffith RL; Bugawan TL; Ziegler R; Alper C; Eisenbarth G
Diabetes; 1991 Apr; 40(4):478-81. PubMed ID: 2010048
[TBL] [Abstract][Full Text] [Related]
5. DNA typing for class II HLA antigens with allele-specific or group-specific amplification. IV. Typing for alleles of the HLA-DR2 group.
Moraes ME; Fernandez-Viña M; Stastny P
Hum Immunol; 1991 Jun; 31(2):139-44. PubMed ID: 2066273
[TBL] [Abstract][Full Text] [Related]
6. Analysis of HLA-DR2-associated polymorphisms by oligonucleotide hybridization in an Asian Indian population.
Mehra NK; Verduijn W; Taneja V; Drabbels J; Singh SP; Giphart MJ
Hum Immunol; 1991 Dec; 32(4):246-53. PubMed ID: 1783571
[TBL] [Abstract][Full Text] [Related]
7. Extensive study of DRB, DQA, and DQB gene polymorphism in 23 DR2-positive, insulin-dependent diabetes mellitus patients.
Zeliszewski D; Tiercy JM; Boitard C; Gu XF; Loche M; Krishnamoorthy R; Simonney N; Elion J; Bach JF; Mach B
Hum Immunol; 1992 Feb; 33(2):140-7. PubMed ID: 1348743
[TBL] [Abstract][Full Text] [Related]
8. Increasing complexity of HLA-DR2 as detected by serology and oligonucleotide typing.
Schreuder GM; van den Berg-Loonen PM; Verduyn W; Geraets DP; Parlevliet J; van Rood JJ; Giphart MJ
Hum Immunol; 1991 Oct; 32(2):141-9. PubMed ID: 1683866
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of major histocompatibility complex allelic associations with systemic lupus erythematosus in Taiwan.
Lu LY; Ding WZ; Fici D; Deulofeut R; Cheng HH; Cheu CC; Sung PK; Schur PH; Fraser PA
Arthritis Rheum; 1997 Jun; 40(6):1138-45. PubMed ID: 9182925
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial diversity in DR2 haplotypes.
Wade JA; Hurley CK; Hastings A; Ehrenberg P; Johnson AH; Martell RW; du Toit ED
Tissue Antigens; 1993 Mar; 41(3):113-8. PubMed ID: 8316942
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte antigen class II polymorphisms and genetic susceptibility of IDDM in Egyptian children.
Gaber SA; Mazzola G; Berrino M; Canale L; Cornaglia M; Ghali I; Sergio Curtoni E; Amoroso A
Diabetes Care; 1994 Nov; 17(11):1341-4. PubMed ID: 7821177
[TBL] [Abstract][Full Text] [Related]
12. T cell defined HLA epitopes and T cell receptor polymorphism in insulin dependent diabetes mellitus.
Sheehy MJ
Baillieres Clin Endocrinol Metab; 1991 Jun; 5(2):341-55. PubMed ID: 1716435
[TBL] [Abstract][Full Text] [Related]
13. A new HLA-DR2 extended haplotype is involved in insulin-dependent diabetes mellitus susceptibility.
Carcassi C; Trucco G; Trucco M; Contu L
Hum Immunol; 1991 Jul; 31(3):159-64. PubMed ID: 1890017
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism and distribution of HLA-DR2 alleles and haplotypes in a Greek population.
Constantinidou N; Chaidaroglou A; Van den Berg-Loonen EM; Koniavitou K
Tissue Antigens; 1998 Aug; 52(2):153-7. PubMed ID: 9756404
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of a recombinant HLA-DR1/DR2 haplotype.
Bidwell JL; Bidwell EA; Dupont E; Andrien M; Bouillenne C; Klouda PT; Bradley BA
Hum Immunol; 1992 Apr; 33(4):289-93. PubMed ID: 1353488
[TBL] [Abstract][Full Text] [Related]
16. Serologic and molecular studies of two kindreds expressing recombinant HLA DR1/DR2 haplotypes.
Wisecarver J; Shepherd S; Beisel K; Rubocki R
Tissue Antigens; 1993 Mar; 41(3):148-54. PubMed ID: 7686308
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in HLA-DR2-related DR,DQ haplotypes in eight populations of Asia-Oceania.
Gao XJ; Serjeantson SW
Immunogenetics; 1991; 34(6):401-8. PubMed ID: 1748488
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor-beta gene RFLP alleles in Finnish IDDM haplotypes. The Childhood Diabetes in Finland (DiMe) Study Group.
Ilonen J; Merivuori H; Reijonen H; Knip M; Akerblom HK; Pociot F; Nerup J
Scand J Immunol; 1992 Dec; 36(6):779-83. PubMed ID: 1361076
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland.
Haegert DG; Swift FV; Benedikz J
Neurology; 1996 Apr; 46(4):1107-11. PubMed ID: 8780100
[TBL] [Abstract][Full Text] [Related]
20. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group.
Fennessy M; Metcalfe K; Hitman GA; Niven M; Biro PA; Tuomilehto J; Tuomilehto-Wolf E
Diabetologia; 1994 Sep; 37(9):937-44. PubMed ID: 7806025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
